<DOC>
	<DOCNO>NCT00368602</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety treatment chronic cutaneous ulcer burn wound topical beta adrenergic antagonist ( Timoptic® ) .</brief_summary>
	<brief_title>Beta Blocker Chronic Wound Healing</brief_title>
	<detailed_description>The purpose study learn heal venous leg ulcer faster test safety drug see effect venous leg ulcer . You : - interviewed examine - physical exam - blood urine test - photograph take wound - apply medication leg ulcer direct</detailed_description>
	<mesh_term>Adrenergic Agents</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Adrenergic Antagonists</mesh_term>
	<criteria>Any race btwn 18 85 year age , inclusive ; Male female , neither pregnant lactating . Informed consent ; Have least 1 low extremity ulcer gaiter area ( knee ankle ) : 1 . Surface area ≥2 sq . cm . ≤20 sq . cm . ; Ulcer large surface area meeting inclusion criterion select . 2 . If 2 ulcer present surface area , ulcer long duration select . 3 . Study ulcer must least 2 cm ulcer extremity . 4 . A viable wound bed free necrotic tissue postdebridement , debridement indicate . 5 . Have Ankle Brachial Index ( ABI ) &gt; 0.7 ; 6 . Presence either dorsalis pedis posterior tibialis pulse Doppler study extremity ; 7 . Have nonhealing ( open ) ulcer least 1 month . Subjects fail conservative therapy eligible study ; 8 . Comply trial ( 13 17 day ) protocolspecified standard care prior randomization ; 9 . Two follow : dermatitis , atrophie blanche , varicosity , hyperpigmentation lipodermatosclerosis ; Decrease wind surface area &gt; 35 % btwn Screening Visit 1 ( Randomization ) ; Cellulitis , osteomyelitis , ulcer expose bone , tendon fascia , purulent exudate ulcer area ; Grade IV ulcer ; Evidence study ulcer infection ; Study ulcer nonvenous etiology ; Acquired known infect HIV ; Uncontrolled diabetes mellitus ; Immunodeficiency define serum IgG , IgA , IgM less onehalf low limit normal ; Severe protein malnutrition define serum albumin &lt; 2.5 g/dL ; Severe anemia define total hemoglobin &lt; 10 g/dL male &lt; 8 g/dL female ; Chronic renal insufficiency require dialysis ; Serum aspartate aminotransferase ( AST , SGOT , GOT ) serum alanine aminotransferase ( ALT , SGPT , GPT ) level great twice upper limit normal ; New York Heart Association Functional Classification IV ; Deep vein thrombosis ( DVT ) w/in last 6 week clinical evidence current DVT ; Arterial revascularization study extremity w/in previous 6 month date Screening Visit ; History , w/in previous 12 month date Screen Visit , alcohol drug abuse , particularly methadone heroin ; Received previous treatment follow 60 day prior Screening : Immunosuppressive agent , radiation , chemotherapy , growth factor site study ulcer , split fullthickness skin graft site study ulcer , biologicallyactive cellular acellular product ( ) site study ulcer , investigational drug device Received previous treatment systemic corticosteroid prior Screening ( Chronic corticosteroid w/in 90 day short course corticosteroid w/in 30 day ) Been hospitalize treatment venous ulcer w/in previous 30 day Screening . Asthma history asthma , obstructive pulmonary disease , myasthenia gravis , hyperthyroidism , history heart block</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>